argenx SE
(STU:1AE)
€
547.6
-1.4 (-0.26%)
Market Cap: 33.15 Bil
Enterprise Value: 30.31 Bil
PE Ratio: 0
PB Ratio: 8.37
GF Score: 80/100 argenx SE at Stifel Virtual Healthcare Conference Transcript
Nov 17, 2020 / 07:00PM GMT
Release Date Price:
€219.4
(+0.18%)
Derek Christian Archila
Stifel, Nicolaus & Company, Incorporated, Research Division - Director & Senior Analyst
All right. I think we'll get started with our next presentation. Welcome to the afternoon portion of day 2 here at the Stifel Healthcare Conference. My name is Derek Archila. I'm one of the senior biotech analysts here at Stifel. I am pleased to introduce our next company, argenx. From the company, we have the Chief Operating Officer, Keith Woods, joining us for our fireside discussion. Keith, how are you doing?
R. Keith Woods
argenx SE - COO
I'm doing great, Derek. It's wonderful to see you today.
Derek Christian Archila
Stifel, Nicolaus & Company, Incorporated, Research Division - Director & Senior Analyst
Likewise, and thanks for joining us. So let's just dive right in here to the Q&A portion.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot